Study on the Vaccination of the Population of Romania against Monkeypox in Terms of Medical Security
- PMID: 36366343
- PMCID: PMC9697308
- DOI: 10.3390/vaccines10111834
Study on the Vaccination of the Population of Romania against Monkeypox in Terms of Medical Security
Abstract
Although it has been shown in numerous studies that immunization of the population by vaccination is the most effective way to protect against smallpox or other polioviruses, the anti-vaccination public rhetoric recorded during the COVID-19 pandemic is likely to influence the populations acceptance of vaccination against newly emerging viruses. This fact influenced our decision to study the vaccination of the Romanian population against the virus that causes monkeypox, aiming to identify the degree of compliance regarding the decision related to vaccination acceptance/non-acceptance/hesitation, based on the survey of a representative sample of respondents. The study is based on an online questionnaire completed between 1 July and 31 July 2022 by 820 individuals, aged 18 years or above, with a permanent residency in Romania. The study was undertaken in order to observe the attitudes of the respondents regarding the acceptance, refusal, or hesitation of vaccination against monkeypox. The sociological data resulting from the application of the questionnaire on 820 people highlighted that 97.16% were vaccinated with the vaccines of the national mandatory scheme and 53.32% were vaccinated with the optional vaccines (rotavirus vaccine, anti-hepatitis A, meningococcal vaccine, etc.). Although 47.13% of respondents considered monkeypox to be a real problem facing humanity today, only 26.37% of those surveyed expressed their fear of becoming infected, and 29.30% were willing to immunize themselves against the virus by vaccination. Only 19.59% of respondents believed that the monkeypox disease will generate a new global pandemic, while 31.86% considered pandemics to be a human security issue, and 30.28% expressed their desire to accept a reduction in some rights and freedoms, in the short term, for the adoption of institutional measures to combat a possible pandemic caused by monkeypox. The study clearly highlights the fact that monkeypox is perceived as a threat to the health of the population, with relatively low acceptance of conspiracy theories regarding its origins/manifestation/consequences among respondents (between 21.7% and 28.9%). The vaccination of the population against monkeypox is strongly influenced by the validity of the results obtained over time, in the vaccination campaigns against the smallpox virus (vaccine found in the mandatory vaccination scheme in Romania until 1979). We believe that the negative public rhetoric regarding the COVID-19 vaccination is likely to negatively influence monkeypox vaccination. Although specialized studies and practical results showed that the immunization of the population through vaccination represents an important vector in the prevention/management of pandemic-type issues, we believe that a national pro-vaccination campaign, based on scientific evidence, can lead the population to accept vaccination when the epidemiological context requires it. We also believe that a culture of health security needs to be developed among citizens to raise awareness of the role of vaccines as an important vector in the field of population health.
Keywords: acceptance; hesitation; human safety; monkeypox; romania; vaccine.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
Survey upon the Reasons of COVID-19 Vaccination Acceptance in Romania.Vaccines (Basel). 2022 Oct 8;10(10):1679. doi: 10.3390/vaccines10101679. Vaccines (Basel). 2022. PMID: 36298544 Free PMC article.
-
Study on the Refusal of Vaccination against COVID-19 in Romania.Vaccines (Basel). 2022 Feb 9;10(2):261. doi: 10.3390/vaccines10020261. Vaccines (Basel). 2022. PMID: 35214719 Free PMC article.
-
Public Perceptions of the Emerging Human Monkeypox Disease and Vaccination in Riyadh, Saudi Arabia: A Cross-Sectional Study.Vaccines (Basel). 2022 Sep 15;10(9):1534. doi: 10.3390/vaccines10091534. Vaccines (Basel). 2022. PMID: 36146612 Free PMC article.
-
Poxvirus Vaccines: Past, Present, and Future.Adv Exp Med Biol. 2024;1451:273-287. doi: 10.1007/978-3-031-57165-7_17. Adv Exp Med Biol. 2024. PMID: 38801584 Review.
-
Strategy of developing nucleic acid-based universal monkeypox vaccine candidates.Front Immunol. 2022 Oct 27;13:1050309. doi: 10.3389/fimmu.2022.1050309. eCollection 2022. Front Immunol. 2022. PMID: 36389680 Free PMC article. Review.
Cited by
-
Intention to receive the monkeypox vaccine and its psychological and sociodemographic predictors: a cross-sectional survey in the general population of Peru.Psicol Reflex Crit. 2023 Dec 18;36(1):39. doi: 10.1186/s41155-023-00281-z. Psicol Reflex Crit. 2023. PMID: 38108935 Free PMC article.
-
Global prevalence and correlates of mpox vaccine acceptance and uptake: a systematic review and meta-analysis.Commun Med (Lond). 2024 Jul 9;4(1):136. doi: 10.1038/s43856-024-00564-1. Commun Med (Lond). 2024. PMID: 38977752 Free PMC article.
-
Perception of and Vaccine Readiness towards Mpox among Men Who Have Sex with Men Living with HIV in China: A Cross-Sectional Study.Vaccines (Basel). 2023 Feb 23;11(3):528. doi: 10.3390/vaccines11030528. Vaccines (Basel). 2023. PMID: 36992114 Free PMC article.
-
Assessment of Knowledge and Concern of People Living with HIV Regarding Human Mpox and Vaccination.Curr HIV Res. 2024;22(2):120-127. doi: 10.2174/011570162X293673240427062123. Curr HIV Res. 2024. PMID: 38698752
-
Global prevalence and determinants associated with the acceptance of monkeypox vaccination.Narra J. 2024 Aug;4(2):e866. doi: 10.52225/narra.v4i2.866. Epub 2024 Jul 17. Narra J. 2024. PMID: 39280280 Free PMC article.
References
LinkOut - more resources
Full Text Sources